Callitas Theraputics Inc., a wholly owned subsidiary of Callitas Health Inc.

admin

About admin

This author has not yet filled in any details.
So far admin has created 52 blog entries.

M Pharmaceutical Inc. Announces Repricing Of Warrants And Options Grant

2017-07-31T10:40:39+00:00

VANCOUVER, B.C., CANADA (January 26, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”), announced today that it has repriced from $0.50 to $0.05 per share 4,375,000 options expiring on February 6 and 1,025,000 options expiring on February 13, 2017. The Company also announced that it has issued stock [...]

M Pharmaceutical Inc. Announces Repricing Of Warrants And Options Grant 2017-07-31T10:40:39+00:00

M Pharmaceutical Inc. Announces Strategy To Seek Distribution Partners For Their Patented Technologies To Deliver Phytoestrogens For The Treatment Of The Symptoms Of Menopause

2017-07-31T10:41:35+00:00

VANCOUVER, B.C., CANADA (January 24, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”), announced today as part of its planned acquisition of 40 J’s, that it will immediately seek marketing and distribution partnerships for the  patented and proprietary topical products for the relief of menopausal symptoms that will [...]

M Pharmaceutical Inc. Announces Strategy To Seek Distribution Partners For Their Patented Technologies To Deliver Phytoestrogens For The Treatment Of The Symptoms Of Menopause 2017-07-31T10:41:35+00:00

M Pharmaceutical Inc. to Remove Parabens from All Future Products

2017-07-31T10:42:34+00:00

VANCOUVER, B.C., CANADA (January 19, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”), announced today as part of its planned acquisition of Cincinnati based 40 J’s, that it will immediately transition all products to paraben-free formulations based on an exclusive license it is acquiring for an innovative, patent [...]

M Pharmaceutical Inc. to Remove Parabens from All Future Products 2017-07-31T10:42:34+00:00

M Pharmaceutical Inc. Announces Plans to Actively Seek Partners To Distribute Its Recently Acquired Technologies for Diabetic Neuropathy Relief

2017-07-31T10:43:26+00:00

VANCOUVER, B.C., CANADA (January 18, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”), announced today as part of its planned acquisition of 40 J’s, that it will immediately seek marketing and distribution partnerships for its topical products for the relief of Diabetic Neuropathy symptoms. “Diabetic Neuropathy, or diabetic [...]

M Pharmaceutical Inc. Announces Plans to Actively Seek Partners To Distribute Its Recently Acquired Technologies for Diabetic Neuropathy Relief 2017-07-31T10:43:26+00:00

M Pharmaceutical Inc. Announces Plans to Develop a Drug Product for Treatment of Female Sexual Dysfunction

2017-07-31T10:44:08+00:00

VANCOUVER, B.C., CANADA (January 12, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”), announced today as part of its planned acquisition of 40 J’s, it will continue to advance the development of a patented (additional patents pending) topical drug product for the treatment of female sexual dysfunction (FSD). [...]

M Pharmaceutical Inc. Announces Plans to Develop a Drug Product for Treatment of Female Sexual Dysfunction 2017-07-31T10:44:08+00:00

M Pharmaceutical Inc. Announces Plans on Expanding Distribution of Successful OTC Products

2017-07-31T10:44:47+00:00

VANCOUVER, B.C., CANADA (January 10, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”), announced today that the Company is moving to build significant infrastructure, perform additional product R&D and focus on international business expansion to increase the level of sales currently achieved by the current owner of their [...]

M Pharmaceutical Inc. Announces Plans on Expanding Distribution of Successful OTC Products 2017-07-31T10:44:47+00:00

Canadian Company Buys Turpin Hills Biotech

2017-07-31T11:42:51+00:00

A Canadian drug company with a Fort Thomas subsidiary that makes products aimed at treating obesity and infertility has purchased a small Cincinnati biotech company working on drugs to address female sexual dysfunction. M Pharmaceutical Inc. of Vancouver, British Columbia, is acquiring 40 J’s LLC of Turpin Hills in exchange for $1.5 million in [...]

Canadian Company Buys Turpin Hills Biotech 2017-07-31T11:42:51+00:00

M Pharmaceutical Inc. Announces That It Will Simultaneously Commercialize And Market Over-The-Counter C-103, Reformulated Orlistat

2017-07-31T11:43:39+00:00

VANCOUVER, B.C., CANADA (January 6, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”), is providing an update of the Company’s strategy for the commercialization of its recently acquired C-103 project; which builds on its November 29th, 2016 press release covering its prescription strength C-103 strategy. M Pharma, working with its contracted partners, [...]

M Pharmaceutical Inc. Announces That It Will Simultaneously Commercialize And Market Over-The-Counter C-103, Reformulated Orlistat 2017-07-31T11:43:39+00:00

M Pharmaceutical Inc. Enters Into Exclusive Negotiations To Acquire 40J’s LLC

2017-07-31T11:46:12+00:00

VANCOUVER, B.C., CANADA (January 4, 2017) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”), is announcing today that the company has executed on a Letter of Intent to acquire the assets of Cincinnati based private research and development partnership 40J’s LLC (and related companies & technologies).  In return for [...]

M Pharmaceutical Inc. Enters Into Exclusive Negotiations To Acquire 40J’s LLC 2017-07-31T11:46:12+00:00

M Pharmaceutical Inc. Seeks To Expand Weight Management & Women’s Health Treatment Portfolio Through Additional Innovative Technologies

2017-07-31T11:47:05+00:00

VANCOUVER, B.C., CANADA (December 22nd, 2016) - M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “M Pharma”), is providing an update regarding its business strategy as it relates to the Company’s focus on weight management and women’s health treatments. M Pharmaceutical Inc. is committed to developing and commercializing its innovative drug treatments [...]

M Pharmaceutical Inc. Seeks To Expand Weight Management & Women’s Health Treatment Portfolio Through Additional Innovative Technologies 2017-07-31T11:47:05+00:00